Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 May 1;161(5):1135-51.
doi: 10.1084/jem.161.5.1135.

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer

A Doyle, W J Martin, K Funa, A Gazdar, D Carney, S E Martin, I Linnoila, F Cuttitta, J Mulshine, P Bunn, et al.

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer

A Doyle et al. J Exp Med. .

Abstract

We have found markedly deficient expression of the class I major histocompatibility antigens HLA-A,B,C and beta 2m on human small-cell lung cancer (SCLC) lines and fresh tumor samples. The deficit of HLA-A,B,C and beta 2-microglobulin (beta 2m) antigen expression was demonstrated with both radiobinding assays and indirect immunofluorescence assays. Immunoprecipitation of metabolically labeled cells with antibodies to class I antigens showed most SCLC lines to have synthesized almost no beta 2m and HLA-A,B,C proteins. Northern blot analysis, using human HLA-A,B, and beta 2m cDNA probes, showed that almost all SCLC lines tested had markedly decreased amounts of HLA and beta 2m mRNA, but both gene products could be induced with interferon treatment of SCLC lines. We conclude that human SCLC, in contrast to other lung cancer types, is characterized by greatly reduced transcription of HLA-A,B,C and beta 2m genes, which suggests the existence of a mechanism for evading the host immune response to the tumor and of an E1a-like product in this type of tumor cell.

PubMed Disclaimer

References

    1. J Histochem Cytochem. 1981 Apr;29(4):577-80 - PubMed
    1. Immunogenetics. 1981;13(4):285-95 - PubMed
    1. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4591-5 - PubMed
    1. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5754-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6613-7 - PubMed

Publication types

MeSH terms